Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

2965

Actual shortage: 237 (8%)
Anticipated shortage: 27 (1%)
Avoided shortage: 9 (0%)
Resolved: 2692 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

25 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-12-12 2019-03-29 69318
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-04 2019-10-01 92984
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-12-05 2020-01-07 100310
APO-ZOLPIDEM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-03-27 2020-05-11 109689
APO-ZOLPIDEM ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-04-01 2020-05-11 110342
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-04-13 2020-12-21 111928
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-04-13 2020-12-21 111931
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-05-08 2020-12-28 114309
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-05-08 2020-12-28 114312
APO-ZOLPIDEM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-09-30 2020-11-19 125369
APO-ZOLPIDEM ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-10-21 2020-11-19 126783
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2021-10-29 2021-11-26 148503
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2021-10-29 2021-12-06 148506
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-05-20 2022-07-22 161032
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-06-17 2022-07-28 162904
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-03-02 2023-06-02 185930
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-04-06 2023-06-02 188968
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-04-27 2023-06-02 190862
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-05-19 2023-06-02 192788
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-06-29 2023-11-06 196949

Showing 21 to 40 of 2965

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-TELMISARTAN/HCTZ 12.5MG 80MG TABLET Discontinued 2018-02-23 2018-09-15 40826
APO-TELMISARTAN/HCTZ 25MG 80MG TABLET Discontinued 2018-02-23 2018-05-07 40829
APO-TELMISARTAN/HCTZ 25MG 80MG TABLET Discontinued 2018-02-23 2018-05-07 40832
APO DIMENHYDRINATE TAB 50MG 50MG TABLET Discontinued 2018-02-23 2018-02-28 40835
APO DIMENHYDRINATE TAB 50MG 50MG TABLET Discontinued 2018-02-23 2018-05-07 40838
ANTI-NAUSEANT 50MG TABLET Discontinued 2018-02-23 2018-09-12 40841
ANTI-NAUSEANT 50MG TABLET Discontinued 2018-02-23 2018-10-25 40844
APO-SALVENT TABLETS - 4MG 4MG TABLET Discontinued 2018-02-23 2018-07-17 40847
APO-SALVENT TABLETS - 2MG 2MG TABLET Discontinued 2018-02-23 2018-12-28 40854
APO-TELMISARTAN/HCTZ 12.5MG 80MG TABLET Discontinued 2018-02-26 2018-02-26 40957
APO-ZOLMITRIPTAN 2.5MG TABLET Discontinued 2018-02-26 2018-02-26 40960
APO-CANDESARTAN/HCTZ 25MG 32MG TABLET Discontinued 2018-02-26 2018-05-03 41011
APO-CANDESARTAN/HCTZ 12.5MG 32MG TABLET Discontinued 2018-02-26 2018-02-26 41020
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-02-26 2018-02-26 41047
APO-CEFPROZIL 500MG TABLET Discontinued 2018-04-04 2018-10-05 44945
APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH 500MG TABLET Discontinued 2018-09-07 2018-09-08 60157
APO-ALENDRONATE 10MG TABLET To be discontinued 2018-09-07 2019-12-20 60163
APO-ATENOL TAB 100MG 100MG TABLET Discontinued 2018-09-07 2018-09-15 60261
APO-ATENOL TAB 50MG 50MG TABLET Discontinued 2018-09-07 2018-09-15 60267
APO-ATORVASTATIN 10MG TABLET To be discontinued 2018-09-07 2018-09-07 60276

Showing 61 to 80 of 356